Literature DB >> 2890706

The characterization of the dopaminergic profile of EMD 23,448, and indolyl-3-butylamine: selective actions on presynaptic and supersensitive postsynaptic DA receptor populations.

M Goldstein1, K Fuxe, E Meller, C A Seyfried, L Agnati, F M Mascagni.   

Abstract

The effects of the dopamine (DA) agonist EMD 23,448 on central normosensitive and supersensitive DA receptors were investigated. EMD 23,448 only slightly inhibits rat striatal DOPA synthesis in vivo and does not inhibit the enhanced striatal DOPA synthesis elicited by acute administration of haloperidol. Also unlike other DA agonists it does not increase striatal acetylcholine levels. However, it inhibits striatal DOPA synthesis in rats with DA receptors rendered supersensitive by chronic treatment with haloperidol. EMD 23,448 also effectively inhibits the enhanced striatal DOPA synthesis elicited by administration of GBL. Furthermore, EMD 23,448 selectively reduces, in a dose-dependant way, DA utilization in nerve terminals of the central caudate and in dotted terminals of the ventral striatum but DA utilization in the substantia nigra is unaffected. The most marked reduction of DA utilization was induced in the anteromedial frontal cortex. These results indicate that EMD 23,448 selectively stimulates presynaptic DA receptors and supersensitive postsynaptic DA receptors. Behavioral experiments in animals with normosensitive and supersensitive DA receptors also indicate that EMD 23,448 effectively stimulates presynaptic and supersensitive postsynaptic DA receptors. Receptor binding studies have shown that EMD 23,448 has a high affinity for the D2 DA receptors, but it ineffectively promotes the coupling of the DA receptors with the guanine nucleotide regulatory protein. However, at supersensitive striatal DA receptors the coupling is shown to be enhanced by EMD 23,448. The selectivity of EMD 23,448 for presynaptic DA receptors might, at least in part, be related to the presence of DA receptor reserves which are sensitive to EMD 23,448. With regard to the selectivity of EMD 23,448 for supersensitive postsynaptic DA receptors an increase in the efficiency of the coupling mechanism upon activation by EMD 23,448 is probably involved.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890706     DOI: 10.1007/bf01253598

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  34 in total

1.  INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM.

Authors:  L J POIRIER; T L SOURKES
Journal:  Brain       Date:  1965-03       Impact factor: 13.501

2.  Liquid chromatographic analysis of catecholamines routine assay for regional brain mapping.

Authors:  R Keller; A Oke; I Mefford; R N Adams
Journal:  Life Sci       Date:  1976-10-01       Impact factor: 5.037

3.  Radiochemical assay for ACh: modifications for sub-picomole measurements.

Authors:  R E McCaman; J Stetzler
Journal:  J Neurochem       Date:  1977-03       Impact factor: 5.372

4.  Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.

Authors:  M P Galloway; M E Wolf; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

5.  Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspects.

Authors:  L F Agnati; K Fuxe; F Benfenati; I Zini; M Zoli; L Fabbri; A Härfstrand
Journal:  Acta Physiol Scand Suppl       Date:  1984

Review 6.  Brain dopamine receptors.

Authors:  P Seeman
Journal:  Pharmacol Rev       Date:  1980-09       Impact factor: 25.468

7.  Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Authors:  K Fuxe; B B Fredholm; L F Agnati; S O Ogren; B J Everitt; G Jonsson; J A Gustafsson
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

8.  Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

Authors:  H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

9.  Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.

Authors:  R Schwarcz; K Fuxe; L F Agnati; T Hökfelt; J T Coyle
Journal:  Brain Res       Date:  1979-07-20       Impact factor: 3.252

10.  Determinations of catecholamine half-lives and turnover rates in discrete catecholamine nerve terminal systems of the hypothalamus, the preoptic region and the forebrain by quantitative histofluorimetry.

Authors:  K Andersson; K Fuxe; L F Agnati
Journal:  Acta Physiol Scand       Date:  1985-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.